Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer
Author:
Affiliation:
1. The Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1743681
Reference95 articles.
1. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
3. Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
4. Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response;Translational Oncology;2024-11
2. Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner;Life Sciences;2024-08
3. GSK3β: A ray of hope for the treatment of diabetic kidney disease;The FASEB Journal;2024-02-05
4. Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer;Translational Oncology;2023-12
5. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy;Expert Review of Anticancer Therapy;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3